We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,295 hedge funds and large institutions have $45.6B invested in Edwards Lifesciences in 2024 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 463 increasing their positions, 465 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 122 | Existing positions closed: 90

7% more funds holding in top 10

Funds holding in top 10: 14 → 15 (+1)

1% more funds holding

Funds holding: 1,279 → 1,295 (+16)

0.67% more ownership

Funds ownership: 81.25% → 81.93% (+0.67%)

0% less repeat investments, than reductions

Existing positions increased: 463 | Existing positions reduced: 465

2% less capital invested

Capital invested by funds: $46.6B → $45.6B (-$1.03B)

7% less call options, than puts

Call options by funds: $276M | Put options by funds: $297M

Holders
1,295
Holders Change
+16
Holders Change %
+1.25%
% of All Funds
18.7%
Holding in Top 10
15
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.14%
% of All Funds
0.22%
New
122
Increased
463
Reduced
465
Closed
90
Calls
$276M
Puts
$297M
Net Calls
-$21M
Net Calls Change
-$59.1M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$348M
2
SFFS
Stonehage Fleming Financial Services
Jersey
+$204M
3
UBS AM
UBS AM
Illinois
+$137M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$122M
5
Swedbank
Swedbank
Sweden
+$109M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$224M
2
Citadel Advisors
Citadel Advisors
Florida
-$179M
3
BlackRock
BlackRock
New York
-$128M
4
JP Morgan Chase
JP Morgan Chase
New York
-$81.7M
5
State Street
State Street
Massachusetts
-$67.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$342M +$6.04M +68,251 +2%
Charles Schwab
27
Charles Schwab
California
$333M +$2.78M +31,349 +0.9%
Ameriprise
28
Ameriprise
Minnesota
$296M +$66.2M +747,771 +30%
VOYA Investment Management
29
VOYA Investment Management
Georgia
$296M -$11.7M -132,220 -4%
N
30
Nuveen
North Carolina
$282M +$42M +474,260 +18%
OCBV
31
Ownership Capital B.V.
Netherlands
$273M -$24M -271,533 -8%
CIP
32
Champlain Investment Partners
Vermont
$272M -$1.42M -15,980 -0.5%
Holocene Advisors
33
Holocene Advisors
New York
$264M -$47.6M -536,990 -16%
CIBC Private Wealth Group
34
CIBC Private Wealth Group
Georgia
$258M -$1.96M -22,165 -0.8%
A
35
AustralianSuper
Australia
$257M +$30.5M +344,465 +14%
Nordea Investment Management
36
Nordea Investment Management
Sweden
$231M +$30.6M +345,183 +16%
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$228M -$22.8M -257,649 -9%
SFFS
38
Stonehage Fleming Financial Services
Jersey
$213M +$204M +2,302,940 New
Capital International Investors
39
Capital International Investors
California
$194M -$10.1M -114,013 -5%
American Century Companies
40
American Century Companies
Missouri
$192M +$3.83M +43,247 +2%
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$190M +$292K +3,299 +0.2%
SAM
42
Storebrand Asset Management
Norway
$184M -$1.03M -11,609 -0.6%
Handelsbanken Fonder
43
Handelsbanken Fonder
Sweden
$173M +$25.9M +292,134 +19%
HSBC Holdings
44
HSBC Holdings
United Kingdom
$171M +$6.22M +70,210 +4%
Macquarie Group
45
Macquarie Group
Australia
$169M -$3.1M -35,043 -2%
RJA
46
Raymond James & Associates
Florida
$169M +$4.44M +50,124 +3%
Primecap Management
47
Primecap Management
California
$167M -$7.97M -90,000 -5%
Swiss National Bank
48
Swiss National Bank
Switzerland
$164M -$3.19M -36,000 -2%
DekaBank Deutsche Girozentrale
49
DekaBank Deutsche Girozentrale
Germany
$157M -$24.7M -278,654 -14%
Artisan Partners
50
Artisan Partners
Wisconsin
$157M +$86.1M +972,733 +134%
1
2
3 4 5

EW Hedge Fund Activity: Q2 2024 in Review

1,295 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2024, worth a combined $45.6B — down 2.2% from $46.6B a quarter earlier.

Buyers outnumbered sellers: 122 funds opened new EW positions and 90 closed out — a net gain of 32 holders — while 463 added to existing stakes and 465 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $348M. The largest seller was Point72 Asset Management, cutting an estimated $224M.

  • 1,295 institutional investors held Edwards Lifesciences (EW) as of Q2 2024, up from 1,279 in Q1 2024.
  • Funds reported $45.6B of Edwards Lifesciences stock for Q2 2024, down 2.2% quarter-over-quarter.
  • 122 funds opened new Edwards Lifesciences positions in Q2 2024 and 90 closed out, a net change of +32 holders.
  • The largest Edwards Lifesciences buyer in Q2 2024 was AllianceBernstein, an estimated $348M added.
  • The largest Edwards Lifesciences seller in Q2 2024 was Point72 Asset Management, an estimated $224M sold.

Based on aggregated 13F filings for Q2 2024.